leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Media > LSD and Psilocybin
December 17, 2009


Eighth Subject Enrolled in LSD Trial

The eighth subject has been enrolled in the MAPS-sponsored clinical trial evaluating LSD to alleviate anxiety associated with a life-threatening illness. The subject has completed the screening process and will be given an experimental LSD session in the coming weeks. Principal investigator Peter Gasser, M.D, is leading the study.

Back to LSD and Psilocybin Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.